This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jeremias, A. Articles by Cutlip, D. E. Search for Related Content PubMed PubMed Citation Articles by Jeremias, A. Articles by Cutlip, D. E.

Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures

Allen Jeremias, MD^*,, Donald S. Baim, MD, FACC^*,, Kalon K.L. Ho, MD, MS, FACC^*,, Manish Chauhan, MD, FACC, Joseph P. Carrozza, Jr, MD, FACC^*, David J. Cohen, MD, MS^*,, Jeffrey J. Popma, MD, FACC, Richard E. Kuntz, MD, MS^*, and Donald E. Cutlip, MD, FACC^*,,*

^* Harvard Clinical Research Institute
Division of Cardiology, Beth Israel Deaconess Medical Center
Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, USA

View larger version (19K): [in a new window]   Figure 1 Incidence of periprocedural myocardial infarction by type (type 1 = creatine kinase-MB [CK-MB] isoenzyme >1 but <3 times normal; type 2 = CK-MB elevation 3 but 8 times normal; type 3 = >8 times normal or Q-wave myocardial infarction) after coronary intervention in patients with successful and unsuccessful procedures.

View larger version (29K): [in a new window]   Figure 2 Mortality among patients with and without periprocedural myocardial infarction (MI) by type (definitions as in Figure 1) and for successful and unsuccessful procedures.

View larger version (15K): [in a new window]   Figure 3 Kaplan-Meier estimates of survival among all patients with and without periprocedural myocardial infarction by type (A, definitions as in Figure 1) and for those with successful procedures only (B). MI = myocardial infarction.